Mint Tower Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Mint Tower Capital Management’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,100	Closed	-$318K	–	467
2021 Q3	$318K	Buy	+18,100	New	+$211K	0.04%	250

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Mint Tower Capital Management's TRIL Position: Q4 2021 in Review

Mint Tower Capital Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 18,100 shares — an estimated $318K sold.

Mint Tower Capital Management first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $318K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Mint Tower Capital Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Mint Tower Capital Management sold 18,100 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $318K.
Mint Tower Capital Management first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Mint Tower Capital Management's Trillium Therapeutics Inc. position peaked at $318K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Mint Tower Capital Management's 13F filing for Q4 2021, filed 4 Feb 2022.